메뉴 건너뛰기




Volumn 41, Issue 4, 2013, Pages 966-973

Prevention of hyperoxia-mediated pulmonary inflammation in neonatal rats by caffeine

Author keywords

Bronchopulmonary dysplasia; Chemokine; Cytokines; Methylxanthine

Indexed keywords

ALPHA CHEMOKINE; CAFFEINE; CC CC-CHEMOKINE MONOCYTE CHEMOATTRACTANT PROTEIN 1; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT 1; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOPEROXIDASE; OXYGEN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

EID: 84875823973     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00012412     Document Type: Article
Times cited : (110)

References (35)
  • 1
    • 77956281923 scopus 로고    scopus 로고
    • Neonatal outcomes of extremely preterm infants from the nichd neonatal research network
    • Stoll BJ, Hansen NI, Bell EF, et al. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics 2010; 126: 443-456.
    • (2010) Pediatrics , vol.126 , pp. 443-456
    • Stoll, B.J.1    Hansen, N.I.2    Bell, E.F.3
  • 2
    • 35848952935 scopus 로고    scopus 로고
    • Chronic lung disease after premature birth
    • Baraldi E, Filippone M. Chronic lung disease after premature birth. N Engl J Med 2007; 357: 1946-1955.
    • (2007) N Engl J Med , vol.357 , pp. 1946-1955
    • Baraldi, E.1    Filippone, M.2
  • 3
    • 0032706843 scopus 로고    scopus 로고
    • The new bpd: An arrest of lung development
    • Jobe AJ. The new BPD: an arrest of lung development. Pediatr Res 1999; 46: 641-643.
    • (1999) Pediatr Res , vol.46 , pp. 641-643
    • Jobe, A.J.1
  • 4
    • 84921430263 scopus 로고    scopus 로고
    • Early (,8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants
    • Halliday HL, Ehrenkranz RA, Doyle LW. Early (,8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev 2010; 1: CD001146.
    • (2010) Cochrane Database Syst Rev , vol.1
    • Halliday, H.L.1    Ehrenkranz, R.A.2    Doyle, L.W.3
  • 5
    • 70349129941 scopus 로고    scopus 로고
    • Animal derived surfactant extract for treatment of respiratory distress syndrome
    • Seger N, Soll R. Animal derived surfactant extract for treatment of respiratory distress syndrome. Cochrane Database Syst Rev 2009; 2: CD007836.
    • (2009) Cochrane Database Syst Rev , vol.2
    • Seger, N.1    Soll, R.2
  • 6
    • 70349252005 scopus 로고    scopus 로고
    • Preterm resuscitation with low oxygen causes less oxidative stress, inflammation, and chronic lung disease
    • Vento M, Moro M, Escrig R, et al. Preterm resuscitation with low oxygen causes less oxidative stress, inflammation, and chronic lung disease. Pediatrics 2009; 124: e439-e449.
    • (2009) Pediatrics , vol.124
    • Vento, M.1    Moro, M.2    Escrig, R.3
  • 7
    • 0033600279 scopus 로고    scopus 로고
    • Vitamin a supplementation for extremely-low-birth-weight infants
    • Tyson JE, Wright LL, Oh W, et al. Vitamin A supplementation for extremely-low-birth-weight infants. N Engl J Med 1999; 340: 1962-1968.
    • (1999) N Engl J Med , vol.340 , pp. 1962-1968
    • Tyson, J.E.1    Wright, L.L.2    Oh, W.3
  • 8
    • 33646681887 scopus 로고    scopus 로고
    • Caffeine therapy for apnea of prematurity
    • Schmidt B, Roberts RS, Davis P, et al. Caffeine therapy for apnea of prematurity. N Engl J Med 2006; 354: 2112-2121.
    • (2006) N Engl J Med , vol.354 , pp. 2112-2121
    • Schmidt, B.1    Roberts, R.S.2    Davis, P.3
  • 10
    • 76749121781 scopus 로고    scopus 로고
    • Caffeine for apnea of prematurity trial: Benefits may vary in subgroups
    • Davis PG, Schmidt B, Roberts RS, et al. Caffeine for apnea of prematurity trial: benefits may vary in subgroups. J Pediatr 2010; 156: 382-387.
    • (2010) J Pediatr , vol.156 , pp. 382-387
    • Davis, P.G.1    Schmidt, B.2    Roberts, R.S.3
  • 11
    • 70449526442 scopus 로고    scopus 로고
    • Effect of caffeine on respiratory muscle strength and lung function in prematurely born, ventilated infants
    • Kassim Z, Greenough A, Rafferty GF. Effect of caffeine on respiratory muscle strength and lung function in prematurely born, ventilated infants. Eur J Pediatr 2009; 168: 1491-1495.
    • (2009) Eur J Pediatr , vol.168 , pp. 1491-1495
    • Kassim, Z.1    Greenough, A.2    Rafferty, G.F.3
  • 12
    • 10744227545 scopus 로고    scopus 로고
    • Gene expression profile and histopathology of experimental bronchopulmonary dysplasia induced by prolonged oxidative stress
    • Wagenaar GT, terHorst SA, van GastelenMA, et al. Gene expression profile and histopathology of experimental bronchopulmonary dysplasia induced by prolonged oxidative stress. Free Radic BiolMed 2004; 36: 782-801.
    • (2004) Free Radic BiolMed , vol.36 , pp. 782-801
    • Wagenaar, G.T.1    TerHorst, S.A.2    Van Gastelen, M.A.3
  • 13
    • 0031843337 scopus 로고    scopus 로고
    • Functional and pathological effects of prolonged hyperoxia in neonatal mice
    • Warner BB, Stuart LA, Papes RA, et al. Functional and pathological effects of prolonged hyperoxia in neonatal mice. Am J Physiol 1998; 275: L110-L117.
    • (1998) Am J Physiol , vol.275
    • Warner, B.B.1    Stuart, L.A.2    Papes, R.A.3
  • 14
    • 33745069841 scopus 로고    scopus 로고
    • Structural aspects of postnatal lung development-Alveolar formation and growth
    • Burri PH. Structural aspects of postnatal lung development-alveolar formation and growth. Biol Neonate 2006; 89: 313-322.
    • (2006) Biol Neonate , vol.89 , pp. 313-322
    • Burri, P.H.1
  • 15
    • 0035710746 scopus 로고    scopus 로고
    • Analysis of relative gene expression data using real-time quantitative pcr and the 2-ddct method
    • Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-DDCT method. Methods 2001; 25: 402-408.
    • (2001) Methods , vol.25 , pp. 402-408
    • Livak, K.J.1    Schmittgen, T.D.2
  • 16
    • 0029999181 scopus 로고    scopus 로고
    • Changes in structure, mechanics, and insulin-like growth factor-related gene expression in the lungs of newborn rats exposed to air or 60% oxygen
    • Han RN, Buch S, Tseu I, et al. Changes in structure, mechanics, and insulin-like growth factor-related gene expression in the lungs of newborn rats exposed to air or 60% oxygen. Pediatr Res 1996; 39: 921-929.
    • (1996) Pediatr Res , vol.39 , pp. 921-929
    • Han, R.N.1    Buch, S.2    Tseu, I.3
  • 17
    • 0034802186 scopus 로고    scopus 로고
    • Nonpeptide cxcr2 antagonist prevents neutrophil accumulation in hyperoxiaexposed newborn rats
    • Auten RL, Richardson RM, White JR, et al. Nonpeptide CXCR2 antagonist prevents neutrophil accumulation in hyperoxiaexposed newborn rats. J Pharmacol Exp Ther 2001; 299: 90-95.
    • (2001) J Pharmacol Exp Ther , vol.299 , pp. 90-95
    • Auten, R.L.1    Richardson, R.M.2    White, J.R.3
  • 18
    • 0034521919 scopus 로고    scopus 로고
    • Lung inflammation in hyperoxia can be prevented by antichemokine treatment in newborn rats
    • Deng H, Mason SN, Auten RL Jr. Lung inflammation in hyperoxia can be prevented by antichemokine treatment in newborn rats. Am J Respir Crit Care Med 2000; 162: 2316-2323.
    • (2000) Am J Respir Crit Care Med , vol.162 , pp. 2316-2323
    • Deng, H.1    Mason, S.N.2    Auten Jr., R.L.3
  • 19
    • 0033838904 scopus 로고    scopus 로고
    • Cytokine response during hyperoxia: Sequential production of pulmonary tumor necrosis factor and interleukin-6 in neonatal rats
    • Ben-Ari J, Makhoul IR, Dorio RJ, et al. Cytokine response during hyperoxia: sequential production of pulmonary tumor necrosis factor and interleukin-6 in neonatal rats. Isr Med Assoc J 2000; 2: 365-369.
    • (2000) Isr Med Assoc J , vol.2 , pp. 365-369
    • Ben-Ari, J.1    Makhoul, I.R.2    Dorio, R.J.3
  • 20
    • 0029817281 scopus 로고    scopus 로고
    • Cytokines in chronic lung disease of prematurity
    • Kotecha S. Cytokines in chronic lung disease of prematurity. Eur J Pediatr 1996; 155: Suppl. 2, S14-S17.
    • (1996) Eur J Pediatr , vol.155 , Issue.SUPPL. 2
    • Kotecha, S.1
  • 21
    • 33745845181 scopus 로고    scopus 로고
    • Inflammation and bronchopulmonary dysplasia: A continuing story
    • Speer CP. Inflammation and bronchopulmonary dysplasia: a continuing story. Semin Fetal Neonatal Med 2006; 11: 354-362.
    • (2006) Semin Fetal Neonatal Med , vol.11 , pp. 354-362
    • Speer, C.P.1
  • 22
    • 79951676230 scopus 로고    scopus 로고
    • Chronic or high dose acute caffeine treatment protects mice against oleic acid-induced acute lung injury via an adenosine a2a receptor-independent mechanism
    • Li J, Li G, Hu JL, et al. Chronic or high dose acute caffeine treatment protects mice against oleic acid-induced acute lung injury via an adenosine A2A receptor-independent mechanism. Eur J Pharmacol 2011; 654: 295-303.
    • (2011) Eur J Pharmacol , vol.654 , pp. 295-303
    • Li, J.1    Li, G.2    Hu, J.L.3
  • 23
    • 1942432613 scopus 로고    scopus 로고
    • Respiratory disorders in preterm and term infants. In: Fanaroff aa, martin rj, eds. Neonatal-perinatal medicine. Diseases of the fetus and infant
    • Miller JM, Fanaroff AA, Martin Jr. Respiratory disorders in preterm and term infants. In: Fanaroff AA, Martin RJ, eds. Neonatal-Perinatal Medicine. Diseases of the Fetus and Infant. Maryland Height, Mosby, 1997; pp. 1040-1065.
    • (1997) Maryland Height, Mosby , pp. 1040-1065
    • Miller, J.M.1    Fanaroff, A.A.2    Martin, J.R.3
  • 25
    • 60449103179 scopus 로고    scopus 로고
    • Caffeine modulates tnf-A production by cord blood monocytes: The role of adenosine receptors
    • Chavez-Valdez R, Wills-Karp M, Ahlawat R, et al. Caffeine modulates TNF-A production by cord blood monocytes: the role of adenosine receptors. Pediatr Res 2009; 65: 203-208.
    • (2009) Pediatr Res , vol.65 , pp. 203-208
    • Chavez-Valdez, R.1    Wills-Karp, M.2    Ahlawat, R.3
  • 26
    • 4143117971 scopus 로고    scopus 로고
    • Caffeine suppresses tnf-A production via activation of the cyclic amp/protein kinase a pathway
    • Horrigan LA, Kelly JP, Connor TJ. Caffeine suppresses TNF-A production via activation of the cyclic AMP/protein kinase A pathway. Int Immunopharmacol 2004; 4: 1409-1417.
    • (2004) Int Immunopharmacol , vol.4 , pp. 1409-1417
    • Horrigan, L.A.1    Kelly, J.P.2    Connor, T.J.3
  • 27
    • 38849133578 scopus 로고    scopus 로고
    • 1, 3,7-trimethylxanthine (caffeine) may exacerbate acute inflammatory liver injury by weakening the physiological immunosuppressive mechanism
    • Ohta A, Lukashev D, Jackson EK, et al. 1,3,7-trimethylxanthine (caffeine) may exacerbate acute inflammatory liver injury by weakening the physiological immunosuppressive mechanism. J Immunol 2007; 179: 7431-7438.
    • (2007) J Immunol , vol.179 , pp. 7431-7438
    • Ohta, A.1    Lukashev, D.2    Jackson, E.K.3
  • 28
    • 0037191418 scopus 로고    scopus 로고
    • Caffeine-induced neuronal death in neonatal rat brain and cortical cell cultures
    • Kang SH, Lee YA, Won SJ, et al. Caffeine-induced neuronal death in neonatal rat brain and cortical cell cultures. Neuroreport 2002; 13: 1945-1950.
    • (2002) Neuroreport , vol.13 , pp. 1945-1950
    • Kang, S.H.1    Lee, Y.A.2    Won, S.J.3
  • 29
    • 78649985801 scopus 로고    scopus 로고
    • Correlation between serum caffeine levels and changes in cytokine profile in a cohort of preterm infants
    • Chavez Valdez R, Ahlawat R, Wills-Karp M, et al. Correlation between serum caffeine levels and changes in cytokine profile in a cohort of preterm infants. J Pediatr 2011; 158: 57-64.
    • (2011) J Pediatr , vol.158 , pp. 57-64
    • Chavez Valdez, R.1    Ahlawat, R.2    Wills-Karp, M.3
  • 30
    • 0021981599 scopus 로고
    • Pharmacokinetics of paraxanthine, one of the primary metabolites of caffeine, in the rat
    • Bortolotti A, Jiritano L, Bonati M. Pharmacokinetics of paraxanthine, one of the primary metabolites of caffeine, in the rat. Drug Metab Dispos 1985; 13: 227-231.
    • (1985) Drug Metab Dispos , vol.13 , pp. 227-231
    • Bortolotti, A.1    Jiritano, L.2    Bonati, M.3
  • 32
    • 0035209620 scopus 로고    scopus 로고
    • International union of pharmacology: Xxv. Nomenclature and classification of adenosine receptors
    • Fredholm BB, Ijzerman AP, Jacobson KA, et al. International Union of Pharmacology: XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 2001; 53: 527-552.
    • (2001) Pharmacol Rev , vol.53 , pp. 527-552
    • Fredholm, B.B.1    Ijzerman, A.P.2    Jacobson, K.A.3
  • 33
    • 33644770260 scopus 로고    scopus 로고
    • Adenosine receptors as therapeutic targets
    • Jacobson KA, Gao ZG. Adenosine receptors as therapeutic targets. Nat Rev Drug Discov 2006; 5: 247-264.
    • (2006) Nat Rev Drug Discov , vol.5 , pp. 247-264
    • Jacobson, K.A.1    Gao, Z.G.2
  • 35
    • 79251568017 scopus 로고    scopus 로고
    • Distinct roles for the a2b adenosine receptor in acute and chronic stages of bleomycininduced lung injury
    • Zhou Y, Schneider DJ, Morschl E, et al. Distinct roles for the A2B adenosine receptor in acute and chronic stages of bleomycininduced lung injury. J Immunol 2011; 186: 1097-1106.
    • (2011) J Immunol , vol.186 , pp. 1097-1106
    • Zhou, Y.1    Schneider, D.J.2    Morschl, E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.